Groundbreaking Donation to Prestigious Institutions

In a significant leap forward for cancer treatment, the Li Ka Shing Foundation has gifted two state-of-the-art "Histotripsy" devices to both the University of Cambridge in the UK and Stanford University School of Medicine in the US. This groundbreaking technology is poised to accelerate the clinical application of non-invasive treatments for liver cancer, opening new pathways for patient care.

A Vision for Health Innovation

The foundation's contribution reflects its steadfast commitment to supporting leading global medical research institutions. By enabling access to cutting-edge technology, the Li Ka Shing Foundation aims to enhance health outcomes and pioneer innovative solutions in the fight against cancer.

What is Histotripsy?

Histotripsy is a revolutionary non-invasive technique that uses ultrasound waves to break down tissue in tumors without harming surrounding healthy tissue. This promising approach not only reduces recovery time but also minimizes the risks associated with traditional surgical methods.

Impact on Patients and Future Research

With this donation, the Li Ka Shing Foundation is taking a critical step towards fostering advancements in cancer treatment. Researchers at both Cambridge and Stanford are now expected to enhance their studies, benefiting patients around the world by integrating cutting-edge technology into their clinical practices.